Celltrion, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a new presentation of STEQEYMA® (ustekinumab-stba), a biosimilar to STELARA® (ustekinumab), in a ...

while Imaavy is given as an intravenous infusion every two weeks. J&J has set a list price of $12,480 per vial for its drug, saying that it is "competitively priced" compared to the other FcRn ...

Johnson & Johnson’s inflammatory disease drug Stelara has been approved in Europe for ulcerative colitis (UC), a new use for the multibillion dollar blockbuster. The European Commission cleared ...

Biologic medications treat ulcerative colitis by reducing inflammation in your body. If other treatments have not helped to manage your symptoms, biologics may be an effective option. Treatment ...

For those who need frequent blood draws or IV (intravenous) treatments, a port can make it easier to access a vein and reduce the number of needle pricks you receive. Most of us are familiar with ...